Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 4 Homosulfanilamide
2. 4-homosulfanilamide
3. Bensulfamide
4. Mafenide
5. Mafylon
6. Maphenid
7. Marfanil
8. Napaltan
9. Sulfabenzamine
10. Sulfamylon
1. 13009-99-9
2. 4-(aminomethyl)benzenesulfonamide Acetate
3. Mafenamide Acetate
4. Mafenide (acetate)
5. Benzenesulfonamide, 4-(aminomethyl)-, Monoacetate
6. Acetic Acid;4-(aminomethyl)benzenesulfonamide
7. Mafatate
8. Rq6lp6z0wy
9. Maphenide Acetate
10. Winthrocine
11. Sulfamilon
12. Alpha-amino-p-toluenesulfonamide
13. Alpha-amino-p-toluenesulfonamide Monoacetate
14. 4-(aminomethyl)benzenesulfonamide Monoacetate
15. Alpha-aminotoluene-4-sulphonamide Monoacetate
16. Einecs 235-855-0
17. Unii-rq6lp6z0wy
18. Mafenide Acetate [usp:jan]
19. Sulfamylon (tn)
20. Mfcd00072089
21. Mafenide Acetate Salt
22. P-toluenesulfonamide, Alpha-amino-, Monoacetate
23. Schembl41627
24. Mafenide Acetate (jan/usp)
25. Mls000069581
26. Mafenide Acetate [mi]
27. Mafenide Acetate [jan]
28. Benzenesulfonamide, 4-(aminomethyl)-, Acetate (1:1)
29. Chembl1201161
30. Mafenide Acetate [vandf]
31. Chebi:31792
32. Hy-b0614a
33. Dtxsid00156334
34. Mafenide Acetate [mart.]
35. Mafenide Acetate [usp-rs]
36. Mafenide Acetate [who-dd]
37. Hms2231m06
38. Hms3259n08
39. Hms3370m14
40. Bcp28537
41. S3647
42. Mafenide Acetate [green Book]
43. Akos000121908
44. Mafenide Acetate [orange Book]
45. Ccg-266920
46. Ds-2178
47. Nc00709
48. 4-(aminomethyl)benzenesulfonimideacetate
49. Mafenide Acetate [usp Monograph]
50. Ac-22835
51. Smr000058778
52. 4-(aminomethyl)benzenesulfonamide (acetate)
53. Db-041939
54. Am20050421
55. Ft-0630395
56. D01166
57. 4-(aminomethyl)benzene-1-sulfonamide; Acetic Acid
58. A806018
59. W-108356
60. .alpha.-amino-p-toluenesulfonamide Monoacetate
61. Q27288250
62. Mafenide Acetate; 4-(aminomethyl)-benzenesulfoamide Monoacetate
63. Mafenide Acetate, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 246.29 g/mol |
---|---|
Molecular Formula | C9H14N2O4S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 246.06742811 g/mol |
Monoisotopic Mass | 246.06742811 g/mol |
Topological Polar Surface Area | 132 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 255 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Mafenide acetate |
Drug Label | Mafenide acetate, USP is a synthetic antimicrobial agent designated chemically as -amino-p-toluenesulfonamide monoacetate. It has the following structural formula:C7H10N2O2SC2H4O2 M.W. 246.29 C7H10N2O2SC2H4O2 M.W. 246.29 Mafenide acetate, USP... |
Active Ingredient | Mafenide acetate |
Dosage Form | For solution |
Route | Topical |
Strength | 5% |
Market Status | Prescription |
Company | Par Form |
2 of 2 | |
---|---|
Drug Name | Mafenide acetate |
Drug Label | Mafenide acetate, USP is a synthetic antimicrobial agent designated chemically as -amino-p-toluenesulfonamide monoacetate. It has the following structural formula:C7H10N2O2SC2H4O2 M.W. 246.29 C7H10N2O2SC2H4O2 M.W. 246.29 Mafenide acetate, USP... |
Active Ingredient | Mafenide acetate |
Dosage Form | For solution |
Route | Topical |
Strength | 5% |
Market Status | Prescription |
Company | Par Form |
Carbonic Anhydrase Inhibitors
A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. (See all compounds classified as Carbonic Anhydrase Inhibitors.)
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Anti-Infective Agents, Local
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Mafenide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mafenide, including repackagers and relabelers. The FDA regulates Mafenide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mafenide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mafenide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mafenide supplier is an individual or a company that provides Mafenide active pharmaceutical ingredient (API) or Mafenide finished formulations upon request. The Mafenide suppliers may include Mafenide API manufacturers, exporters, distributors and traders.
click here to find a list of Mafenide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mafenide DMF (Drug Master File) is a document detailing the whole manufacturing process of Mafenide active pharmaceutical ingredient (API) in detail. Different forms of Mafenide DMFs exist exist since differing nations have different regulations, such as Mafenide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mafenide DMF submitted to regulatory agencies in the US is known as a USDMF. Mafenide USDMF includes data on Mafenide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mafenide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mafenide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mafenide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mafenide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mafenide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mafenide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mafenide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mafenide suppliers with NDC on PharmaCompass.
Mafenide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mafenide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mafenide GMP manufacturer or Mafenide GMP API supplier for your needs.
A Mafenide CoA (Certificate of Analysis) is a formal document that attests to Mafenide's compliance with Mafenide specifications and serves as a tool for batch-level quality control.
Mafenide CoA mostly includes findings from lab analyses of a specific batch. For each Mafenide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mafenide may be tested according to a variety of international standards, such as European Pharmacopoeia (Mafenide EP), Mafenide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mafenide USP).
LOOKING FOR A SUPPLIER?